DK1545553T3 - Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter - Google Patents

Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Info

Publication number
DK1545553T3
DK1545553T3 DK03766336.6T DK03766336T DK1545553T3 DK 1545553 T3 DK1545553 T3 DK 1545553T3 DK 03766336 T DK03766336 T DK 03766336T DK 1545553 T3 DK1545553 T3 DK 1545553T3
Authority
DK
Denmark
Prior art keywords
alkylphosphocholines
combination
antitumor drugs
antitumor
drugs
Prior art date
Application number
DK03766336.6T
Other languages
English (en)
Inventor
Herbert Sindermann
Juergen Engel
Eckhard Guenther
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1545553T3 publication Critical patent/DK1545553T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03766336.6T 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter DK1545553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30
PCT/EP2003/008346 WO2004012744A1 (de) 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Publications (1)

Publication Number Publication Date
DK1545553T3 true DK1545553T3 (da) 2011-09-12

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03766336.6T DK1545553T3 (da) 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Country Status (27)

Country Link
US (3) US8389497B2 (da)
EP (2) EP2301551A1 (da)
JP (1) JP2005535688A (da)
KR (3) KR20110102485A (da)
CN (1) CN1302780C (da)
AR (1) AR040717A1 (da)
AT (1) ATE516036T1 (da)
AU (2) AU2003253350B2 (da)
BR (1) BR0313048A (da)
CA (1) CA2493023C (da)
CY (1) CY1111902T1 (da)
DK (1) DK1545553T3 (da)
ES (1) ES2369535T3 (da)
HK (1) HK1080751A1 (da)
HR (1) HRP20050184B1 (da)
IL (1) IL166329A (da)
MX (1) MXPA05001203A (da)
NO (1) NO335196B1 (da)
NZ (1) NZ538428A (da)
PL (1) PL375493A1 (da)
PT (1) PT1545553E (da)
RU (1) RU2005105693A (da)
SI (1) SI1545553T1 (da)
TW (1) TWI332007B (da)
UA (1) UA82322C2 (da)
WO (1) WO2004012744A1 (da)
ZA (1) ZA200500453B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003253350B2 (en) 2002-07-30 2008-06-26 Aeterna Zentaris Gmbh Use of alkyl phosphocholines in combination with antitumor medicaments
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
WO2009018233A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
WO2007071658A2 (en) * 2005-12-19 2007-06-28 Æterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
WO2010068925A1 (en) * 2008-12-11 2010-06-17 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219972A1 (de) * 1991-07-04 1993-01-07 Asta Medica Ag Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n-methylpiperidino)-ethyl)-phosphat und verfahren zu dessen herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
AU756805B2 (en) * 1998-01-22 2003-01-23 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
JP2002531534A (ja) * 1998-12-04 2002-09-24 マックス−デルブルック−セントラム フュール モレクラーレ メディツィン タモキシフェン含有リポソーム系腫瘍治療剤
CA2356736A1 (en) * 1998-12-21 2000-06-29 Inkeysa. S.A. Use of etherlysophospholipids as antiinflammatory agents
ES2705016T3 (es) * 2001-02-19 2019-03-21 Novartis Int Pharmaceutical Ag Derivado de rapamicina para el tratamiento de cáncer de pulmón
NZ528394A (en) * 2001-03-23 2005-06-24 Shire Biochem Inc Pharmaceutical combinations for the treatment of cancer comprising dioxolane analogues and nuceloside analogues and/or chemotherapeutic agents
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
BR0215454A (pt) * 2002-01-02 2004-11-23 Pharmacia Italia Spa Terapia combinada contra tumores, comprendendo derivados de acriloil-distamicina substituìdos e inibidores de proteìna cinase (serina/treonina cinase)
AU2003253350B2 (en) 2002-07-30 2008-06-26 Aeterna Zentaris Gmbh Use of alkyl phosphocholines in combination with antitumor medicaments
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
CA2794513A1 (en) * 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Also Published As

Publication number Publication date
HK1080751A1 (en) 2006-05-04
ATE516036T1 (de) 2011-07-15
US20040097470A1 (en) 2004-05-20
TW200404073A (en) 2004-03-16
ZA200500453B (en) 2005-08-31
US20100189784A1 (en) 2010-07-29
EP1545553B1 (de) 2011-07-13
KR20050026028A (ko) 2005-03-14
NO335196B1 (no) 2014-10-20
US8507710B2 (en) 2013-08-13
PL375493A1 (en) 2005-11-28
CN1671397A (zh) 2005-09-21
US20100190738A1 (en) 2010-07-29
TWI332007B (en) 2010-10-21
US8389497B2 (en) 2013-03-05
SI1545553T1 (sl) 2011-09-30
EP2301551A1 (de) 2011-03-30
EP1545553A1 (de) 2005-06-29
BR0313048A (pt) 2005-06-14
AU2008203060B2 (en) 2011-04-21
AU2008203060A1 (en) 2008-07-31
AR040717A1 (es) 2005-04-20
AU2003253350A1 (en) 2004-02-23
HRP20050184B1 (hr) 2014-04-11
IL166329A0 (en) 2006-01-15
AU2003253350B2 (en) 2008-06-26
WO2004012744A1 (de) 2004-02-12
KR20110102485A (ko) 2011-09-16
CA2493023C (en) 2012-01-31
NO20051040L (no) 2005-02-25
JP2005535688A (ja) 2005-11-24
UA82322C2 (uk) 2008-04-10
CN1302780C (zh) 2007-03-07
IL166329A (en) 2012-08-30
NZ538428A (en) 2006-09-29
MXPA05001203A (es) 2005-06-08
PT1545553E (pt) 2011-09-12
KR20130016413A (ko) 2013-02-14
CY1111902T1 (el) 2015-11-04
KR101066804B1 (ko) 2011-09-22
CA2493023A1 (en) 2004-02-12
US8551977B2 (en) 2013-10-08
HRP20050184A2 (en) 2005-04-30
ES2369535T3 (es) 2011-12-01
RU2005105693A (ru) 2005-07-10

Similar Documents

Publication Publication Date Title
FIC20240008I1 (fi) Elvitegraviiri ja tenofoviirialafenamidi
DK2609948T3 (da) Infusionsindretning i form af plaster
DE602005007068D1 (de) Steckdose mit gegenschutz und ausrichtungsmitteln
NO20031447L (no) Paclitaxel-basert antitumor-formulering
HK1091199A1 (en) Quinazoline derivatives and use thereof in the manufacture of medicaments
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
DE60327864D1 (de) Ballondissektor mit kanüle
DE602004004953D1 (de) Kochfeld mit Benutzerschnittstelle und beliebiger Positionierung
DK1581297T3 (da) Kateter med enhedsbestanddel
NO20053529D0 (no) Lymfotoksin-beta-reseptormedikamenter i kombinasjon med kjemoterapeutiske midler
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
NO20043313L (no) Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
HK1080751A1 (en) Use of alkyl phosphocholines in combination with antitumor medicaments
DE602005024291D1 (de) Kamerasystem und kamera-hauptkörper
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1541137T3 (da) Transdermalt delivery system af gestoden
DK1603919T3 (da) 7-Iminoderivater af camptothecin med antitumoraktivitet
FI20050297A (fi) Gelatiinittomat kalvot, joilla on parannetut sulkuominaisuudet
FI20031458A (fi) Kantopakkaus ja pakkauksen kantorakenne
SE0302310D0 (sv) Naturmedel med potenshöjande samt canserförhindrande egenskap
SE0301112D0 (sv) Naturmedel med potenshöjande samt canserförhindrande egenskap
SE0300557D0 (sv) Naturmedel med potenshöjande samt mot cancerförebyggande egenskap
SE0400969D0 (sv) Aryl glycine derivatives and their use
SE0300509D0 (sv) Naturmedel med potenshöjande egenskap